We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIE:EURONEXT PARISVeolia Environnement SA Analysis

Data as of 2026-03-10 - not real-time

$1.71

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Viewbix Inc. is trading well below its discounted cash flow fair‑value estimate, indicating a sizable valuation gap. The stock is positioned beneath its short‑term and medium‑term simple moving averages, confirming a bearish price momentum. RSI hovers around the neutral midpoint, while the MACD histogram has turned slightly positive, suggesting limited short‑term upside. Volume has been rising, yet the market capitalization remains modest and daily turnover is low, underscoring liquidity constraints. The company reports deep operating losses, negative margins and a negative earnings per share, which erodes confidence in near‑term profitability.
Volatility over the past month is exceptionally high and the historical maximum drawdown exceeds eighty percent, flagging a high risk profile. Beta is below one, indicating limited correlation with broader market swings, but sector exposure to fast‑changing digital advertising adds medium sector risk. No dividend is paid, and cash flow is negative despite a positive free‑cash‑flow figure that appears unsustainable. The firm’s balance sheet shows more debt than equity, raising concerns about financial flexibility in a downturn. Given these mixed signals, the stock may present a speculative upside for value‑oriented investors if a turnaround materialises, but the downside risks remain pronounced.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below key moving averages
  • negative earnings and margins
  • elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • valuation gap versus DCF
  • potential improvement in cash generation
  • persistent sector competition

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • sustained operating losses
  • high historical drawdown
  • limited financial cushion

Key Metrics & Analysis

Financial Health

Revenue Growth-56.70%
Profit Margin-199.04%
ROE-279.34%
ROA-13.69%
Debt/Equity64.71
P/B Ratio3.3
Op. Cash Flow$-2998000
Free Cash Flow$3.8M
Industry P/E18.3

Technical Analysis

TrendBearish
RSI49.2
Support$1.39
Resistance$1.86
MA 20$1.71
MA 50$1.74
MA 200$2.99
MACDBullish
VolumeIncreasing
Fear & Greed Index78.18

Valuation

Fair Value$4.77
GradeUndervalued
TypeValue

Risk Assessment

Beta0.48
Volatility72.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.